Publication
Rituximab in Pemphigus Foliaceous With Autoantibodies Against Both Desmoglein 1 and Desmoglein 3
| dc.contributor.author | Carvalho, R | |
| dc.contributor.author | Maio, P | |
| dc.contributor.author | Cunha, D | |
| dc.contributor.author | Freitas, I | |
| dc.contributor.author | Afonso, A | |
| dc.contributor.author | Cardoso, J | |
| dc.date.accessioned | 2015-10-16T16:43:57Z | |
| dc.date.available | 2015-10-16T16:43:57Z | |
| dc.date.issued | 2011 | |
| dc.identifier | 10.1684/ejd.2011.1288 | |
| dc.identifier.citation | Eur J Dermatol. 2011 May-Jun;21(3):415-6 | pt_PT |
| dc.identifier.doi | 10.1684/ejd.2011.1288 | |
| dc.identifier.uri | http://hdl.handle.net/10400.17/2310 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | John Libbey Eurotext | pt_PT |
| dc.subject | HCC DER | pt_PT |
| dc.subject | HCC PAT CLIN | pt_PT |
| dc.subject | Antibodies, Monoclonal, Murine-Derived/therapeutic use | pt_PT |
| dc.subject | Antigens, CD20 | pt_PT |
| dc.subject | Autoantibodies/immunology | pt_PT |
| dc.subject | Desmoglein 1/immunology | pt_PT |
| dc.subject | Desmoglein 3/immunology | pt_PT |
| dc.subject | Follow-Up Studies | pt_PT |
| dc.subject | Immunologic Factors/therapeutic use | pt_PT |
| dc.subject | Pemphigus/drug therapy | pt_PT |
| dc.subject | Pemphigus/immunology | pt_PT |
| dc.title | Rituximab in Pemphigus Foliaceous With Autoantibodies Against Both Desmoglein 1 and Desmoglein 3 | pt_PT |
| dc.type | other | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 416 | pt_PT |
| oaire.citation.startPage | 415 | pt_PT |
| oaire.citation.title | European Journal of Dermatology | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | other | pt_PT |